The effect of dexmedetomidine on pediatric emergence delirium under general anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042575

Enrollment

Unknown

Registered

2021-01-23

Start date

2021-01-13

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Delirium

Interventions

P1:dexmedetomidine 2mcg/kg, nasal drop, 30min before the operation

P2:dexmedetomidine 1mcg/kg, nasal drop, 30min before the operation

C:saline 0.02ml/kg, nasal drop, 30min before the operation

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 3-7 years; 2.Pediatric patient with multiple carries and needs dental treatment under general anesthesia; 3.No systematic disease,ASA level 1-2.

Exclusion criteria

Exclusion criteria: 1.Congenital organic diseases; 2.Growth retardation; 3.Liver and kidney dysfunction; 4.Attention deficit hyperactivity disorder and autism; 5.Allergic to dexmedetomidine; 6.Refusal from the parents.

Design outcomes

Primary

Measure	Time frame
pediatric anesthesia emergence delirium scale;	—

Secondary

Measure	Time frame
parental separation anxiety scale;Ramsay score;Mask acceptance scale;Watcha scale;	—

Countries

China

Contacts

Public ContactHe Huan

Shanghai Stomatological Hospital, Fudan University

hehuandr@163.com+86 13636448188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026